Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Biochimica Et Biophysica Acta|June 23, 1986
The catalytic active site of thioredoxin: conformation and homology with bovine pancreatic trypsin inhibitorC A Lunn, P Pak, J Van Savage, et al.Hematology (Amsterdam, Netherlands)|July 16, 2005
Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host diseaseR A Lunn, N Sumar, A S Bansal, et al.Journal of Bacteriology|June 1, 1987
Association of thioredoxin with the inner membrane and adhesion sites in Escherichia coliM E Bayer, M H Bayer, C A Lunn, et al.The Veterinary Record|December 2, 1989
Behaviour of cows in cubicles and its possible relationship with laminitis in replacement dairy heifersP Colam-Ainsworth, G A Lunn, R C Thomas, et al.Behavioural Pharmacology|August 16, 2021
Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley ratsAngela M Thomas, Kaley J Cargile, Jannelle A Lunn, et al.Plos One|September 3, 2014
Identifying the cause of toxicity of a saline mine waterRick A van Dam, Andrew J Harford, Simon A Lunn, et al.The Journal of Biological Chemistry|August 25, 1984
Amplification and purification of plasmid-encoded thioredoxin from Escherichia coli K12C A Lunn, S Kathju, B J Wallace, et al.The Journal of Biological Chemistry|June 10, 1994
Importance of the loop connecting A and B helices of human interferon-gamma in recognition by interferon-gamma receptorD Lundell, C A Lunn, M M Senior, et al.British Journal of Pharmacology|July 3, 2007
Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primatesW Gonsiorek, C A Lunn, X Fan, et al.Journal of Biomolecular Screening|January 28, 2009
Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assayDebra McGuinness, Asra Malikzay, Richard Visconti, et al.Pageof 7